DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Deferoxamine (Deferoxamine Mesylate) - Current Clinical Trials


Deferoxamine Related Clinical Trials

High-Dose Deferoxamine in Intracerebral Hemorrhage [Suspended]

Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation [Terminated]

Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion [Completed]

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload [Completed]

Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both [Recruiting]

Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial [Recruiting]

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions [Completed]

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions [Completed]

Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload [Completed]

N-acetylcysteine Plus Deferoxamine for Patients With Hypotension [Completed]

Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients [Completed]

Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage [Completed]

Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage [Terminated]

Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major [Completed]

Combo Chelation Trial [Completed]

Efficacy Study in Removing Excess Iron From the Heart [Completed]

Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients [Completed]

Deferoxamine for the Treatment of Hemochromatosis [Completed]

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias [Recruiting]

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients [Completed]

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias [Completed]

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases [Terminated]

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis [Completed]

Pilot Study for Patients With Poor Response to Deferasirox [Completed]

Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml) [Not yet recruiting]

Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). [Completed]

Therapeutic Effects of Silymarin in Patients With B-thalassemia Major [Active, not recruiting]

Modulation of Cerebral Blood Flow Using Iron Chelators [Completed]

Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease [Approved for marketing]

Efficacy Study of the Use of Sequential DFP-DFO Versus DFP [Completed]

Amlodipine for Myocardial Iron in Thalassemia [Active, not recruiting]

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) [Completed]

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study [Completed]

Combination Iron Chelation Therapy [Completed]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017